H26.21
Cataract with neovascularization
Clinical Classification Guidelines
Code Also
- , if applicable, associated condition, such as:
- chronic iridocyclitis (H20.1-)
Medical Intelligence & Overview
Cataracts are a common eye condition that causes clouding of the eye's natural lens, leading to vision impairment. When combined with neovascularization—a process where new, abnormal blood vessels grow into the eye—this condition can complicate diagnosis and treatment. This article explains what cataracts with neovascularization are, their causes, symptoms, methods of diagnosis, and potential management options.
Causes & Symptoms
Clinical Causes: Age-related degeneration Diabetes mellitus, which promotes abnormal blood vessel growth Eye injuries or inflammation that trigger neovascularization Other vascular eye diseases that lead to abnormal vessel formation Genetic predisposition to vascular growth in ocular tissues
Key Symptoms: Gradual loss of peripheral or central vision Blurred or distorted vision Sensitivity to glare or bright lights Colors appearing duller or faded Presence of floaters or shadowy areas in vision Possible eye redness or swelling if inflammation is involved
Diagnostic & Treatment
Diagnosis Path: Visual acuity tests to assess clarity of vision Slit-lamp examination to observe the lens and anterior structures of the eye Fundus examination to evaluate the retina and underlying structures Fundus fluorescein angiography, which uses a special dye to visualize abnormal blood vessels Optical coherence tomography (OCT) to obtain detailed images of ocular tissues
Treatment Protocols: Surgical removal of the cataract punctuated by lens replacement, often necessary when vision impairment affects daily activities Laser therapy, such as panretinal photocoagulation, to reduce abnormal blood vessel growth Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents to inhibit neovascularization Controlling underlying conditions like diabetes to prevent progression Regular monitoring to assess changes in vascular growth and vision status
Clinical Advice & FAQs
Billing Guidance
Is H26.21 a billable ICD-10 code?
Yes, H26.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H26.21?
Clinical documentation must specify the nature of Cataract with neovascularization and any associated comorbidities for accurate reporting.
Cite this Clinical Reference